Vertebral fractures studies back Cortoss
This article was originally published in Clinica
Executive Summary
Orthovita's Cortoss synthetic biomaterial for treating osteoporotic vertebral compression fractures has yielded positive initial 12-month follow-up results in two US pilot trials involving 40 patients.